Washington, D.C. 20549

                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934

                          Coventure International Inc.
                                (Name of Issuer)

                         Common Stock, $0.0001 Par Value
                         (Title of Class of Securities)

                                   222891 10 3
                                 (CUSIP Number)

                                   John Hromyk
                          404 First Street West, Unit 3
                            Cochrane, Alberta T4C 1A5
                                 (403) 851-2600
           (Name, Address and Telephone Number of Person Authorized to
                       Receive Notices and Communications)

                                 August 18, 2004
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d.-1(g), check
the following box [ ].

CUSIP No.     222891 10 3


1) Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons
   (entities only):

   John Hromyk


2) Check the Appropriate Box if a Member of a Group (See Instructions)



3) SEC Use Only


4) Sources of Funds (See Instructions): PF


5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d)
   or 2(e)


6) Citizenship  or  Place  of  Organization:     Canada

Number of          (7)  Sole Voting Power:       5,984,678
Shares Bene-
ficially           (8)  Shared Voting Power          -0-
Owned by
Each Report-       (9)  Sole Dispositive Power:  5,984,678
ing Person
With              (10)  Shared Dispositive Power     -0-


11) Aggregate Amount Beneficially Owned by Each Reporting Person:



12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See


13) Percent of Class Represented by Amount in Row (11):


14) Type of Reporting Person (See Instructions): IN


Item 1.  Security and Issuer

         This statement relates to the common stock, $0.0001 par value ("Common
Stock") of Coventure International Inc., a Delaware corporation (the "Issuer").
The principal executive offices of the Issuer are presently located at 404 First
Street West, Unit 3, Cochrane, Alberta T4C 1A5.

Item 2.  Identity and Background

         This statement is filed by John Hromyk, whose business address is 404
First Street West, Unit 3, Cochrane, Alberta T4C 1A5. Mr. Hromyk is the
President and a Director of the Issuer.

         During the last five (5) years, John Hromyk has not been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors).

         During the last five (5) years, John Hromyk has not been a party to a
civil proceeding of a judicial or administrative body of competent jurisdiction
as a result of which such person was or is subject to a judgment, decree or
final order enjoining final violations of, or prohibiting or mandating
activities subject to federal or state securities laws or finding any violation
with respect to such laws.

         Mr. Hromyk is a citizen of Canada.

Item 3.  Source and Amount of Funds or Other Consideration

         Mr. Hromyk sold 70,222 common shares (1% of the issued and outstanding
common stock) for $49,155.40 in a market transaction on August 18, 2004.

Item 4.  Purpose of Transaction

         Mr. Hromyk sold the stock to reinvest a portion of it back into the
Company to pay off some liabilities and accounts payables.

         John Hromyk is an officer, director and major shareholder of the
Issuer, and is seeking candidates for merger with or acquisition by the Issuer.

         Mr. Hromyk reserves the right to actively pursue various proposals
which could relate to or would result in:

     a.  The acquisition by any person of additional securities of the Issuer,
         or the disposition of securities of the Issuer;

     b.  An extraordinary corporate transaction, such as a merger,
         reorganization or liquidation, involving the Issuer or any of its

     c.  A sale or transfer of a material amount of assets of the Issuer or any
         of its subsidiaries;

     d.  Any change in the present board of directors or management of the
         Issuer, including any plans or proposals to change the number or term
         of directors or to fill any existing vacancies on the board;

     e.  Any material change in the present capitalization or dividend policy of
         the Issuer;

     f.  Any other material change in the Issuer's business or corporate

     g.  Changes in the Issuer's charter, by-laws or instruments corresponding
         thereto or other actions which may impede the acquisition of control of
         the Issuer by any person;

     h.  Causing a class of securities of the Issuer to be delisted from a
         national securities exchange or to cease to be authorized to be quoted
         in an inter-dealer quotation system of a registered national securities

     i.  A class of equity securities of the Issuer becoming eligible for
         termination of registration pursuant to Section 12(g)(4) of the Act;

     j.  Any action similar to any of those enumerated above.

Item 5.  Interest in Securities of the Issuer

         (a) See the cover page of this Schedule
         (b) See the cover page of this Schedule
         (c) On August 18, 2004 John Hromyk sold 70,222 common shares in a
             market transaction for $49,155.40 cash.

Item 6.  Contracts, Arrangements, Understandings or Relationships
         with respect to the Securities of the Issuer.


Item 7.  Material to be Filed as Exhibits.



         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and

Dated:   August 19, 2004

/s/ John Hromyk
John Hromyk